Biora Therapeutics, Inc. (BIOR) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts BIOR Hot Sheet
Join SI Premium – FREE
Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
